Preferred Label : Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency;
Symbol : LSMFLAD;
CISMeF acronym : LSMFLAD;
Type : Phenotype, molecular basis known;
Description : Bradley et al. (1969) described the case of a 25-year-old woman, offspring of first-cousin
parents, with myopathy involving the muscles of the neck and proximal limbs. Muscle
biopsy showed interfibrillar and subsarcolemmal vacuoles; histochemical study, normal
type-II muscle fibers with excessive neutral fat and free fatty acids in type-I fibers
and electron microscopy, degenerate mitochondria. The defect may reside in the pathway
of free fatty acid oxidation. A specific lipase may be deficient. See 212160. *FIELD*
SA Martyn et al. (1981) *FIELD* RF 1. Bradley, W. G.; Hudgson, P.; Gardner-Medwin,
D.; Walton, J. N. : Myopathy associated with abnormal lipid metabolism in skeletal
muscle. Lancet 293: 495-498, 1969. Note: Originally Volume 1. 2. Martyn, C.; Jellinek,
E. H.; Webb, J. N.: Lipid storage myopathy: successful treatment with propranolol.
Brit. Med. J. 282: 1997-1998, 1981. *FIELD* CS Autosomal recessive;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the flavin adenine dinucleotide synthetase 1 gene (FLAD1, 610595.0001);
Laboratory abnormalities : Increased serum creatine kinase (in some patients); Organic aciduria; Increased plasma acylcarnitine species; Increased urinary ethylmalonic acid; Increased urinary adipic acid;
Prefixed ID : #255100;
Origin ID : 255100;
UMLS CUI : C4310822;
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)